Cypherpunk Technologies, Inc. (CYPH)
2.56
+0.20
(+8.47%)
USD |
NASDAQ |
Nov 03, 14:22
Cypherpunk Technologies Price to Book Value : 1.980 for Nov. 3, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 1.826 |
| October 30, 2026 | 2.305 |
| October 29, 2026 | 2.560 |
| October 28, 2026 | 2.506 |
| October 27, 2026 | 2.425 |
| October 26, 2026 | 2.189 |
| October 23, 2026 | 2.181 |
| October 22, 2026 | 2.305 |
| October 21, 2026 | 2.576 |
| October 20, 2026 | 2.174 |
| October 19, 2026 | 1.957 |
| October 16, 2026 | 1.988 |
| October 15, 2026 | 2.336 |
| October 14, 2026 | 2.027 |
| October 13, 2026 | 2.197 |
| October 12, 2026 | 2.243 |
| October 09, 2026 | 2.274 |
| October 08, 2026 | 2.174 |
| October 07, 2026 | 2.359 |
| October 06, 2026 | 2.522 |
| October 05, 2026 | 2.452 |
| October 02, 2026 | 2.344 |
| October 01, 2026 | 2.259 |
| September 30, 2026 | 2.576 |
| September 29, 2026 | 2.498 |
| Date | Value |
|---|---|
| September 28, 2026 | 2.560 |
| September 25, 2026 | 3.187 |
| September 24, 2026 | 3.156 |
| September 23, 2026 | 2.792 |
| September 22, 2026 | 2.885 |
| September 21, 2026 | 2.630 |
| September 18, 2026 | 2.785 |
| September 17, 2026 | 2.375 |
| September 16, 2026 | 1.887 |
| September 15, 2026 | 1.717 |
| September 14, 2026 | 1.996 |
| September 11, 2026 | 1.752 |
| September 10, 2026 | 1.702 |
| September 09, 2026 | 1.895 |
| September 08, 2026 | 2.034 |
| September 04, 2026 | 1.872 |
| September 03, 2026 | 1.756 |
| September 02, 2026 | 1.300 |
| September 01, 2026 | 1.323 |
| August 31, 2026 | 1.412 |
| August 28, 2026 | 1.323 |
| August 27, 2026 | 1.462 |
| August 26, 2026 | 1.261 |
| August 25, 2026 | 1.269 |
| August 24, 2026 | 1.300 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Indaptus Therapeutics, Inc. | 38.55 |
| Cue Biopharma, Inc. | 44.66 |
| Yarrow Bioscience, Inc. | 0.5151 |
| Faeth Therapeutics, Inc. | 2.949 |
| Pyxis Oncology, Inc. | 9.122 |
Price to Book Value Related Metrics
| PE Ratio | 4.526 |
| Price | 2.56 |
| Earnings Yield | 22.09% |
| Market Cap | 275.88M |